Hemispherx Can't Duck Suit Over $2.1M Exec Bonuses
A Delaware Chancery judge on Tuesday refused to throw out a shareholder suit challenging Hemispherx Biopharma Inc.'s $2.1 million in bonuses for executives who led a doubling of the biotech's market...To view the full article, register now.
Already a subscriber? Click here to view full article